Accession Number : ADA322136
Title : Bedtime Administration of Melatonin to Healthy Females Does Not Alter Menstrual Characteristics.
Descriptive Note : Final rept.,
Corporate Author : ARMY AEROMEDICAL RESEARCH LAB FORT RUCKER AL
Personal Author(s) : Kirby, Albert W. ; Comperatore, Carlos A. ; Arroya, Santiago ; Clayton, Melanie ; Ferry, Charles
PDF Url : ADA322136
Report Date : JAN 1997
Pagination or Media Count : 26
Abstract : Rapid travel across multiple time zones often results in fatigue, sleepiness, insomnia, and poor mental performance. These symptoms, in addition to others, often are known as jet lag or desynchronosis. Melatonin, an endogenously occurring hormone, has been shown to be capable of resynchronizing circadian rhythm disruptions and inducing sleep in humans, and therefore can be effective in preventing sleep loss and maintaining alertness during travel. However, in females, melatonin has a potential inhibitory influence on the hypothalamo-pituitary-ovarian axis, and its use may result in secondary disruptions of the menstrual cycle. The study reported here was double blind and placebo controlled and was undertaken to determine whether exogenous melatonin (10 mg), given at bedtime for 7 consecutive days, would have an effect on menstrual characteristics. Our results show that during the late follicular and early luteal phase of the monthly cycle, exogenous melatonin has no apparent effect on menstrual characteristics. There were no systematic monthly surge in luteinizing hormone. Under the specific conditions reported here, any effect of exogenous melatonin on menstrual characteristics should not be a concern.
Descriptors : *FEMALES, *MENSTRUATION, *MELATONIN, HORMONES, CIRCADIAN RHYTHMS, PERFORMANCE(HUMAN), TRAVEL, SLEEP DEPRIVATION, INHIBITION, PLACEBOS, MENTAL ABILITY, FATIGUE(PHYSIOLOGY), JET LAG, PITUITARY HORMONES, INSOMNIA.
Subject Categories : Biochemistry
Anatomy and Physiology
Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE